Week 96 safety and efficacy of the novel HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced participants infected with multi-drug resistant HIV-1 (BRIGHTE study)

Lataillade, M.;Lalezari, J.;Aberg, J.;Molina, J-M.;Kozal, M.;Cahn, P.;Thompson, M.;Diaz, R.;Castagna, A.;Gummel, M.;Gartland, M.;Pierce, A.;Ackerman, P.;Llamoso, C.

2019-01-01